162 related articles for article (PubMed ID: 27464833)
1. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells.
Ah-Koon L; Lesage D; Lemadre E; Souissi I; Fagard R; Varin-Blank N; Fabre EE; Schischmanoff O
J Cell Mol Med; 2016 Oct; 20(10):1956-65. PubMed ID: 27464833
[TBL] [Abstract][Full Text] [Related]
2. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
Sun G; Jin S; Baskaran R
Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
[TBL] [Abstract][Full Text] [Related]
3. Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses.
Wagner MW; Li LS; Morales JC; Galindo CL; Garner HR; Bornmann WG; Boothman DA
J Biol Chem; 2008 Aug; 283(31):21382-93. PubMed ID: 18480061
[TBL] [Abstract][Full Text] [Related]
4. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.
Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P
Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814
[TBL] [Abstract][Full Text] [Related]
5. ATM is activated in response to N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA alkylation.
Adamson AW; Kim WJ; Shangary S; Baskaran R; Brown KD
J Biol Chem; 2002 Oct; 277(41):38222-9. PubMed ID: 12151394
[TBL] [Abstract][Full Text] [Related]
6. The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.
Kim WJ; Beardsley DI; Adamson AW; Brown KD
Toxicol Appl Pharmacol; 2005 Jan; 202(1):84-98. PubMed ID: 15589979
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
[TBL] [Abstract][Full Text] [Related]
8. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
[TBL] [Abstract][Full Text] [Related]
9. Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
Wesierska-Gadek J; Gueorguieva M; Schloffer D; Uhl M; Wojciechowski J
J Cell Biochem; 2003 Aug; 89(6):1222-34. PubMed ID: 12898520
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
Jaiswal AS; Multani AS; Pathak S; Narayan S
Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
[TBL] [Abstract][Full Text] [Related]
11. MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N'-nitro-N'-nitrosoguanidine.
Kim WJ; Rajasekaran B; Brown KD
J Biol Chem; 2007 Nov; 282(44):32021-31. PubMed ID: 17804421
[TBL] [Abstract][Full Text] [Related]
12. p53 Phosphorylation at serine 15 is required for transcriptional induction of the plasminogen activator inhibitor-1 (PAI-1) gene by the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine.
Parra M; Jardí M; Koziczak M; Nagamine Y; Muñoz-Cánoves P
J Biol Chem; 2001 Sep; 276(39):36303-10. PubMed ID: 11470783
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-N'-nitro-N-nitrosoguanidine activates cell-cycle arrest through distinct mechanisms activated in a dose-dependent manner.
Beardsley DI; Kim WJ; Brown KD
Mol Pharmacol; 2005 Oct; 68(4):1049-60. PubMed ID: 15994368
[TBL] [Abstract][Full Text] [Related]
14. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis.
Li LS; Morales JC; Hwang A; Wagner MW; Boothman DA
J Biol Chem; 2008 Aug; 283(31):21394-403. PubMed ID: 18480060
[TBL] [Abstract][Full Text] [Related]
15. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
Carethers JM; Hawn MT; Chauhan DP; Luce MC; Marra G; Koi M; Boland CR
J Clin Invest; 1996 Jul; 98(1):199-206. PubMed ID: 8690794
[TBL] [Abstract][Full Text] [Related]
16. Histone H2AX is a critical factor for cellular protection against DNA alkylating agents.
Meador JA; Zhao M; Su Y; Narayan G; Geard CR; Balajee AS
Oncogene; 2008 Sep; 27(43):5662-71. PubMed ID: 18542054
[TBL] [Abstract][Full Text] [Related]
17. Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.
Izumchenko E; Saydi J; Brown KD
DNA Repair (Amst); 2012 Dec; 11(12):951-64. PubMed ID: 23062884
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Youlyouz-Marfak I; Gachard N; Le Clorennec C; Najjar I; Baran-Marszak F; Reminieras L; May E; Bornkamm GW; Fagard R; Feuillard J
Cell Death Differ; 2008 Feb; 15(2):376-85. PubMed ID: 17992189
[TBL] [Abstract][Full Text] [Related]
19. The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicity.
Tomaszowski KH; Aasland D; Margison GP; Williams E; Pinder SI; Modesti M; Fuchs RP; Kaina B
DNA Repair (Amst); 2015 Apr; 28():14-20. PubMed ID: 25703834
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity.
Bai P; Hegedus C; Erdélyi K; Szabó E; Bakondi E; Gergely S; Szabó C; Virág L
Toxicol Lett; 2007 May; 170(3):203-13. PubMed ID: 17428624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
